We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Curious about Humana (HUM) Q2 Performance? Explore Wall Street Estimates for Key Metrics
Read MoreHide Full Article
The upcoming report from Humana (HUM - Free Report) is expected to reveal quarterly earnings of $6.32 per share, indicating a decline of 9.2% compared to the year-ago period. Analysts forecast revenues of $31.78 billion, representing an increase of 8.2% year over year.
The current level reflects a downward revision of 0.1% in the consensus EPS estimate for the quarter over the past 30 days. This demonstrates how the analysts covering the stock have collectively reappraised their initial projections over this period.
Before a company announces its earnings, it is essential to take into account any changes made to earnings estimates. This is a valuable factor in predicting the potential reactions of investors toward the stock. Empirical research has consistently shown a strong correlation between trends in earnings estimate revisions and the short-term price performance of a stock.
While investors usually depend on consensus earnings and revenue estimates to assess the business performance for the quarter, delving into analysts' forecasts for certain key metrics often provides a more comprehensive understanding.
Bearing this in mind, let's now explore the average estimates of specific Humana metrics that are commonly monitored and projected by Wall Street analysts.
Analysts predict that the 'Revenues- Premiums' will reach $30.23 billion. The estimate suggests a change of +7.4% year over year.
The collective assessment of analysts points to an estimated 'Revenues- Services' of $1.31 billion. The estimate suggests a change of +19% year over year.
The combined assessment of analysts suggests that 'Revenues- Investment income (loss)' will likely reach $270.96 million. The estimate points to a change of -9.1% from the year-ago quarter.
Analysts expect 'Revenue- Insurance' to come in at $30.71 billion. The estimate indicates a change of +7.7% from the prior-year quarter.
According to the collective judgment of analysts, 'Benefits Expense Ratio - Consolidated' should come in at 89.5%. Compared to the current estimate, the company reported 89.0% in the same quarter of the previous year.
It is projected by analysts that the 'Medical Membership - Medicare stand-alone PDP' will reach 2.45 million. Compared to the present estimate, the company reported 2.34 million in the same quarter last year.
The consensus among analysts is that 'Medical Membership - State-based contracts and other' will reach 1.62 million. The estimate compares to the year-ago value of 1.39 million.
The consensus estimate for 'Medical Membership - Group Medicare Advantage' stands at 562.63 thousand. The estimate compares to the year-ago value of 544.90 thousand.
Analysts forecast 'Medical Membership - Medicare Supplement' to reach 419.63 thousand. Compared to the current estimate, the company reported 339.20 thousand in the same quarter of the previous year.
Based on the collective assessment of analysts, 'Medical Membership - Individual Medicare Advantage' should arrive at 5.18 million. The estimate is in contrast to the year-ago figure of 5.62 million.
The average prediction of analysts places 'Medical Membership - Total Medicare' at 8.19 million. The estimate is in contrast to the year-ago figure of 8.50 million.
Analysts' assessment points toward 'Medical Membership - Military services' reaching 4.94 million. The estimate compares to the year-ago value of 5.96 million.
Humana shares have witnessed a change of -1.6% in the past month, in contrast to the Zacks S&P 500 composite's +4.9% move. With a Zacks Rank #3 (Hold), HUM is expected closely follow the overall market performance in the near term. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> .
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Curious about Humana (HUM) Q2 Performance? Explore Wall Street Estimates for Key Metrics
The upcoming report from Humana (HUM - Free Report) is expected to reveal quarterly earnings of $6.32 per share, indicating a decline of 9.2% compared to the year-ago period. Analysts forecast revenues of $31.78 billion, representing an increase of 8.2% year over year.
The current level reflects a downward revision of 0.1% in the consensus EPS estimate for the quarter over the past 30 days. This demonstrates how the analysts covering the stock have collectively reappraised their initial projections over this period.
Before a company announces its earnings, it is essential to take into account any changes made to earnings estimates. This is a valuable factor in predicting the potential reactions of investors toward the stock. Empirical research has consistently shown a strong correlation between trends in earnings estimate revisions and the short-term price performance of a stock.
While investors usually depend on consensus earnings and revenue estimates to assess the business performance for the quarter, delving into analysts' forecasts for certain key metrics often provides a more comprehensive understanding.
Bearing this in mind, let's now explore the average estimates of specific Humana metrics that are commonly monitored and projected by Wall Street analysts.
Analysts predict that the 'Revenues- Premiums' will reach $30.23 billion. The estimate suggests a change of +7.4% year over year.
The collective assessment of analysts points to an estimated 'Revenues- Services' of $1.31 billion. The estimate suggests a change of +19% year over year.
The combined assessment of analysts suggests that 'Revenues- Investment income (loss)' will likely reach $270.96 million. The estimate points to a change of -9.1% from the year-ago quarter.
Analysts expect 'Revenue- Insurance' to come in at $30.71 billion. The estimate indicates a change of +7.7% from the prior-year quarter.
According to the collective judgment of analysts, 'Benefits Expense Ratio - Consolidated' should come in at 89.5%. Compared to the current estimate, the company reported 89.0% in the same quarter of the previous year.
It is projected by analysts that the 'Medical Membership - Medicare stand-alone PDP' will reach 2.45 million. Compared to the present estimate, the company reported 2.34 million in the same quarter last year.
The consensus among analysts is that 'Medical Membership - State-based contracts and other' will reach 1.62 million. The estimate compares to the year-ago value of 1.39 million.
The consensus estimate for 'Medical Membership - Group Medicare Advantage' stands at 562.63 thousand. The estimate compares to the year-ago value of 544.90 thousand.
Analysts forecast 'Medical Membership - Medicare Supplement' to reach 419.63 thousand. Compared to the current estimate, the company reported 339.20 thousand in the same quarter of the previous year.
Based on the collective assessment of analysts, 'Medical Membership - Individual Medicare Advantage' should arrive at 5.18 million. The estimate is in contrast to the year-ago figure of 5.62 million.
The average prediction of analysts places 'Medical Membership - Total Medicare' at 8.19 million. The estimate is in contrast to the year-ago figure of 8.50 million.
Analysts' assessment points toward 'Medical Membership - Military services' reaching 4.94 million. The estimate compares to the year-ago value of 5.96 million.
View all Key Company Metrics for Humana here>>>Humana shares have witnessed a change of -1.6% in the past month, in contrast to the Zacks S&P 500 composite's +4.9% move. With a Zacks Rank #3 (Hold), HUM is expected closely follow the overall market performance in the near term. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> .